These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8965200)

  • 1. Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the serotonin transporter.
    Jagust WJ; Eberling JL; Biegon A; Taylor SE; VanBrocklin HF; Jordan S; Hanrahan SM; Roberts JA; Brennan KM; Mathis CA
    J Nucl Med; 1996 Jul; 37(7):1207-14. PubMed ID: 8965200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats.
    Biegon A; Mathis CA; Hanrahan SM; Jagust WJ
    Brain Res; 1993 Aug; 619(1-2):236-46. PubMed ID: 8374782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bromine-76-labelled 5-bromo-6-nitroquipazine for PET studies of the serotonin transporter.
    Lundkvist C; Loc'h C; Halldin C; Bottlaender M; Ottaviani M; Coulon C; Fuseau C; Mathis C; Farde L; Mazière B
    Nucl Med Biol; 1999 Jul; 26(5):501-7. PubMed ID: 10473188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. I. In vitro studies.
    Mathis CA; Taylor SE; Biegon A; Enas JD
    Brain Res; 1993 Aug; 619(1-2):229-35. PubMed ID: 8374781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of the 5-hydroxytryptamine reuptake site in primate brain using single photon emission computed tomography and [123I]5-iodo-6-nitroquipazine.
    Jagust WJ; Eberling JL; Roberts JA; Brennan KM; Hanrahan SM; VanBrocklin H; Enas JD; Biegon A; Mathis CA
    Eur J Pharmacol; 1993 Sep; 242(2):189-93. PubMed ID: 8253114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.
    Lin KJ; Yen TC; Wey SP; Hwang JJ; Ye XX; Tzen KY; Fu YK; Chen JC
    J Nucl Med; 2004 Apr; 45(4):673-81. PubMed ID: 15073265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a fluorine-18-labelled derivative of 6-nitroquipazine, as a radioligand for the in vivo serotonin transporter imaging with PET.
    Karramkam M; Dollé F; Valette H; Besret L; Bramoullé Y; Hinnen F; Vaufrey F; Franklin C; Bourg S; Coulon C; Ottaviani M; Delaforge M; Loc'h C; Bottlaender M; Crouzel C
    Bioorg Med Chem; 2002 Aug; 10(8):2611-23. PubMed ID: 12057650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain.
    Madras BK; Gracz LM; Meltzer PC; Liang AY; Elmaleh DR; Kaufman MJ; Fischman AJ
    Synapse; 1998 Jun; 29(2):105-15. PubMed ID: 9593101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity.
    Reneman L; Booij J; Habraken JB; De Bruin K; Hatzidimitriou G; Den Heeten GJ; Ricaurte GA
    Synapse; 2002 Dec; 46(3):199-205. PubMed ID: 12325046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.
    de Win MM; de Jeu RA; de Bruin K; Habraken JB; Reneman L; Booij J; den Heeten GJ
    Eur Neuropsychopharmacol; 2004 May; 14(3):185-9. PubMed ID: 15056477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
    Kung MP; Hou C; Oya S; Mu M; Acton PD; Kung HF
    Eur J Nucl Med; 1999 Aug; 26(8):844-53. PubMed ID: 10436197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
    Zhuang Z; Choi S; Hou C; Mu M; Kung M; Acton PD; Kung HF
    Nucl Med Biol; 2000 Feb; 27(2):169-75. PubMed ID: 10773546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.
    Scheffel U; Szabo Z; Mathews WB; Finley PA; Dannals RF; Ravert HT; Szabo K; Yuan J; Ricaurte GA
    Synapse; 1998 Jun; 29(2):183-92. PubMed ID: 9593108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.
    Semple DM; Ebmeier KP; Glabus MF; O'Carroll RE; Johnstone EC
    Br J Psychiatry; 1999 Jul; 175():63-9. PubMed ID: 10621770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
    Choi SR; Hou C; Oya S; Mu M; Kung MP; Siciliano M; Acton PD; Kung HF
    Synapse; 2000 Dec; 38(4):403-12. PubMed ID: 11044887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.